case_images: PMC6886342_01
case_images: Prophase and induction phase of the GRAALL-2014 protocol for patients aged >45 years.
case_images: CRIHEM2019-9086570.001.jpg
case_images: PMC6886342_01_CRIHEM2019-9086570.001.jpg
case_images: fig1
case_images: After a seven-day prophase of steroids, the induction phase was composed of five drugs and prophylaxis of the central nervous system (CNS) involvement by repeated intrathecal injections (Figure 1).
case_images: Variation of liver biologic parameters from D11 to D30 of the induction phase.
case_images: CRIHEM2019-9086570.002.jpg
case_images: PMC6886342_01_CRIHEM2019-9086570.002.jpg
case_images: fig2
case_images: Evolution of hepatic parameters between D11 and D30 of the induction phase is described in Figure 2.
case_images: Variation of liver biologic parameters from D30 to D43 of the induction phase.
case_images: CRIHEM2019-9086570.003.jpg
case_images: PMC6886342_01_CRIHEM2019-9086570.003.jpg
case_images: fig3
case_images: D30 and D43 of the induction phase is described in Figure 3; variation of bile acids and ammonemia from D30 to D43 is depicted in Figure 4. Deep sedation was stopped at day 41, and consciousness improved.
case_images: Variation of bile acids and ammonemia from D30 to D43 of the induction phase.
case_images: CRIHEM2019-9086570.004.jpg
case_images: PMC6886342_01_CRIHEM2019-9086570.004.jpg
case_images: fig4
case_images: D30 and D43 of the induction phase is described in Figure 3; variation of bile acids and ammonemia from D30 to D43 is depicted in Figure 4. Deep sedation was stopped at day 41, and consciousness improved.